Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001193125-25-206439

Chief Financial Officer acquired 701 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fuhrman Alan · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-15 Grant or award : show line 1 in the form +701 $9.13 $6,399 14,788 D
Loading xslF345X05/ownership.xml…